These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8218756)

  • 1. Anti-secretory effects and pharmacokinetics of low dose ranitidine.
    Koss MA; Hogan DL; Lane J; Steinbach JH; Isenberg JI
    Aliment Pharmacol Ther; 1993 Aug; 7(4):417-22. PubMed ID: 8218756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ranitidine and of cimetidine on pentagastrin-stimulated gastric acid secretion.
    Holloway RH; Kuljian B; Eshelman F; McCallum RW
    Clin Pharmacol Ther; 1984 Feb; 35(2):203-7. PubMed ID: 6319068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ranitidine bismuth citrate on gastric acid secretion and gastrin release in subjects with and without Helicobacter pylori infection.
    Ciociola AA; Webb DD; Heath A; Walsh JH
    Aliment Pharmacol Ther; 1996 Dec; 10(6):905-12. PubMed ID: 8971287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.
    Ballesteros MA; Hogan DL; Koss MA; Isenberg JI
    Ann Intern Med; 1990 Mar; 112(5):334-9. PubMed ID: 2306061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric secretion in response to a meal 12-13 h after ranitidine.
    Frislid K; Berstad A
    Scand J Gastroenterol; 1985 Aug; 20(6):711-4. PubMed ID: 3929374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
    Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
    Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of basal gastric acid secretion on the pharmacodynamics of ranitidine.
    Sanders SW; Ballersteros MA; Hogan DL; Koss MA; Isenberg JI
    Chronobiol Int; 1991; 8(3):186-93. PubMed ID: 1794156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine upon meal-induced gastric secretion: oral pharmacokinetics and plasma concentration effect relationships.
    Mignon M; Chau NP; Nguyen-Phuoc BK; Sauvage M; Leguy F; Bonfils S
    Br J Clin Pharmacol; 1982 Aug; 14(2):187-93. PubMed ID: 6125203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
    Hurlimann S; Abbühl B; Inauen W; Halter F
    Aliment Pharmacol Ther; 1994 Apr; 8(2):193-201. PubMed ID: 8038351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
    Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
    Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intragastric pH and pharmacokinetics of intravenous ranitidine during sinusoidal and constant-rate infusions.
    Sanders SW; Bishop AL; Moore JG
    Chronobiol Int; 1991; 8(4):267-76. PubMed ID: 1797416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects.
    Boyce M; David O; Darwin K; Mitchell T; Johnston A; Warrington S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):181-9. PubMed ID: 22607579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of single and multiple doses of oral ranitidine on the gastric transit of an indigestible capsule in humans.
    Mojaverian P; Vlasses PH; Parker S; Warner C
    Clin Pharmacol Ther; 1990 Mar; 47(3):382-8. PubMed ID: 2178854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology.
    Watson RG; Johnston BT; Tham TC; Kersey K
    Aliment Pharmacol Ther; 1996 Dec; 10(6):913-8. PubMed ID: 8971288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter- and intrasubject variations of ranitidine pharmacokinetics after oral administration to normal male subjects.
    Shim CK; Hong JS
    J Pharm Sci; 1989 Dec; 78(12):990-4. PubMed ID: 2614701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and bioequivalence study of ranitidine film tablets in healthy male subjects.
    Gschwend MH; Guserle R; Erenmemişoglu A; Martin W; Tamur U; Kanzik I; Hincal AA
    Arzneimittelforschung; 2007; 57(6):315-9. PubMed ID: 17688076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ranitidine on gastric acid hypersecretion in an infant with short bowel syndrome.
    Hyman PE; Garvey TQ; Harada T
    J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):316-9. PubMed ID: 3921686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.
    Londong W; Londong V; Ruthe C; Weizert P
    Gut; 1981 Jul; 22(7):542-8. PubMed ID: 6114900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.